A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02345161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1811

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Triple FF/UMEC/VI
DRUG: Placebo to match FF/UMEC/VI
DRUG: Budesonide/Formoterol
DRUG: Placebo to match Budesonide/Formoterol combination
DRUG: Albuterol/salbutamol

Sponsor

GlaxoSmithKline